2024
DOI: 10.3390/cancers16030621
|View full text |Cite
|
Sign up to set email alerts
|

A Validated Methodological Approach to Prove the Safety of Clinical Electromagnetic Induction Systems in Magnetic Hyperthermia

Maria Anastasia Rouni,
Boaz Shalev,
George Tsanidis
et al.

Abstract: The present study focuses on the development of a methodology for evaluating the safety of MNH systems, through the numerical prediction of the induced temperature rise in superficial skin layers due to eddy currents heating under an alternating magnetic field (AMF). The methodology is supported and validated through experimental measurements of the AMF’s distribution, as well as temperature data from the torsos of six patients who participated in a clinical trial study. The simulations involved a computationa… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 34 publications
0
1
0
Order By: Relevance
“…For this reason, there is a need to develop new therapies, with one such option being Magnetic Field Hyperthermia (MH) [4]. MH has been recently trialled in human clinical studies that have demonstrated the safety and feasibility of it as an approach to treating several different cancers [5,6], including metastatic tumours [7,8]. During MH, magnetic nanoparticles (MNPs) are injected into a tumour site [9] or delivered through intravenous injection (IV).…”
Section: Introductionmentioning
confidence: 99%
“…For this reason, there is a need to develop new therapies, with one such option being Magnetic Field Hyperthermia (MH) [4]. MH has been recently trialled in human clinical studies that have demonstrated the safety and feasibility of it as an approach to treating several different cancers [5,6], including metastatic tumours [7,8]. During MH, magnetic nanoparticles (MNPs) are injected into a tumour site [9] or delivered through intravenous injection (IV).…”
Section: Introductionmentioning
confidence: 99%